BillionToOne, Inc.
Market Cap
$3.20B
P/E Ratio
498.29
EPS
$0.14
Dividend Yield
0.00%
52-Week Range
$61.96 — $138.70
Volume
278.33K
Avg Volume
269.61K
Beta
6.30
P/E (TTM)
498.29
Forward P/E
536.62
PEG Ratio
8.91
P/S (TTM)
10.53
P/B (TTM)
6.70
P/FCF
618.80
EV/EBITDA
559.37x
EV/Sales
—
ROE (TTM)
0.01%
ROA (TTM)
0.01%
ROIC
0.03%
Gross Margin
0.68%
Operating Margin
0.05%
Net Margin
0.02%
Debt/Equity
0.23
Current Ratio
11.69
EPS Growth (YoY)
+1.10%
Revenue Growth (YoY)
+1.17%
EPS Growth (3Y)
+0.25%
EPS Growth (5Y)
—
Sales Growth (3Y)
+0.56%
Sales Growth (5Y)
—
EPS Est (This Year)
$0.13
EPS Est (Next Year)
$0.78
Dividend Yield
—
Annual Dividend
—
Payout Ratio
0.00%
Frequency
—
Ex-Dividend Date
—
Cash/Share
$10.83
Buy
1 = Strong Buy, 5 = Strong Sell
Price Target Range
Consensus Target: $133.67(91.6% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
45.77M
Float
5.43M
Free Float %
11.87%
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Country
US
Exchange
NASDAQ
IPO Date
2025-11-06
Employees
620
CEO
Oguzhan Atay
Index Membership
—
Website
https://www.billiontoone.com
BillionToOne, Inc. (BLLN) is a healthcare company in the medical - diagnostics & research industry listed on the NASDAQ. With a market capitalization of $3.20B, a P/E ratio of 498.29, BLLN is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare BLLN against other stocks using dozens of fundamental and technical filters.
BillionToOne, Inc. (BLLN) has a trailing twelve-month (TTM) P/E ratio of 498.29. This is above the market average, which may reflect high growth expectations or premium valuation. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, BillionToOne, Inc. (BLLN) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
BillionToOne, Inc. (BLLN) has a market capitalization of $3.20 billion, classifying it as a mid-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Wall Street analysts have a consensus "Buy" rating on BillionToOne, Inc. (BLLN) with an average score of 2.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $133.67 implies 91.6% upside from the current price.